Voyager Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Voyager Therapeutics (Nasdaq: VYGR), a gene therapy innovator, has announced its participation in two upcoming virtual investor conferences. The company will present at the SVB Leerink 11th Annual Global Healthcare Conference on Feb. 18, 2022, at 9:20 a.m. ET, and participate in a corporate panel at the Cowen 42nd Annual Health Care Conference on Mar. 9, 2022, at 12:50 p.m. ET. Investors can access the sessions on Voyager's website and replays will be available for at least 30 days.

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) technologies, today announced that it will participate in the following virtual investor conferences.

• SVB Leerink 11^th Annual Global Healthcare Conference, company presentation, Feb. 18, 2022, 9:20 a.m. ET
• Cowen 42^nd Annual Health Care Conference, corporate panel discussion, Mar. 9, 2022, 12:50 p.m. ET

The sessions may be accessed from the Investors section of Voyager’s website at www.voyagertherapeutics.com. Replays of the webcasts will be archived on the Company's website for at least 30 days.

About Voyager Therapeutics
Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the technology to treat devastating diseases. Proprietary capsids born from the Company’s TRACER™ screening platform are powering a rich early-stage pipeline of new and second-generation programs and may elevate the field to overcome the limitations of conventional gene therapy vectors across neurologic disorders and other therapeutic areas.
voyagertherapeutics.com    LinkedIn         Twitter

Investor Inquiries:        
investors@voyagertherapeutics.com

Media Inquiries:        
Scott Santiamo
ssantiamo@voyagertherapeutics.com

 

FAQ

When will Voyager Therapeutics participate in the SVB Leerink conference?

Voyager Therapeutics will present at the SVB Leerink 11th Annual Global Healthcare Conference on Feb. 18, 2022, at 9:20 a.m. ET.

What is the date of the Cowen Annual Health Care Conference for Voyager?

Voyager Therapeutics will participate in the Cowen 42nd Annual Health Care Conference on Mar. 9, 2022, at 12:50 p.m. ET.

How can I access the virtual investor conferences for VYGR?

The virtual investor conferences for Voyager can be accessed through the Investors section of their website at www.voyagertherapeutics.com.

Will the presentations from the investor conferences be available later?

Yes, replays of the webcasts from Voyager Therapeutics' presentations will be archived on their website for at least 30 days.

What is the main focus of Voyager Therapeutics?

Voyager Therapeutics is focused on developing next-generation adeno-associated virus (AAV) gene therapies to treat serious diseases.